title: IBD LIVE Case Series--Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.
authors.affiliation: *Pediatric GI Fellow PGY-5, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; †Marcus Professor of Pediatric Gastroenterology/Inflammatory Bowel Diseases, Professor of Human Genetics, Scientific Director of Pediatric IBD program/Children's Healthcare of Atlanta; Co-Director, Children's Center for Transplantation and Immune mediated Disorders (CTID), Department of Pediatrics and Human Genetics, Emory University School of Medicine, Atlanta, Georgia; and Children's Healthcare of Atlanta, Atlanta, Georgia; ‡Professor of Pediatrics, University of Pittsburgh School of Medicine, Director, Inflammatory Bowel Disease Center; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; §Assistant Professor, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; ‖Director, Anatomic Pathology, Professor, Department of Pathology, Division of Pediatric Pathology, Children's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; ¶Associate Professor, Director, Inflammatory Bowel Disease Program, Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Maryland; **Associate Professor of Medicine and of The Dartmouth Institute for Health Policy & Clinical Practice at the Geisel School of Medicine; Director, Dartmouth-Hitchcock Inflammatory Bowel Disease Center Department of Medicine, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and ††Professor of Medicine, Associate Chief for Education, Co-Director, Inflammatory Bowel Disease Center, Head, IBD Clinical Program, Department of Medicine, Division of Gastroenterology
authors.forename: Whitney M
authors.initials: WM
authors.lastname: Sunseri
authors.forename: Subra
authors.initials: S
authors.lastname: Kugathasan
authors.forename: David J
authors.initials: DJ
authors.lastname: Keljo
authors.forename: Julia B
authors.initials: JB
authors.lastname: Greer
authors.forename: Sarangarajan
authors.initials: S
authors.lastname: Ranganathan
authors.forename: Raymond K
authors.initials: RK
authors.lastname: Cross
authors.forename: Corey A
authors.initials: CA
authors.lastname: Siegel
authors.forename: Miguel D
authors.initials: MD
authors.lastname: Regueiro
mesh_terms: D002648:Child; D003424:Crohn Disease / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D004502:Education, Medical, Continuing; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use; D008297:Male; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000097:blood
chemical_list: D005765:Gastrointestinal Agents; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human; D000069285:Infliximab